CmaxInsight’s Innovative R&D Approach integrates meaningful insights from real-world and clinical data to help you chart a more predictable and efficient path to product approval and beyond.

CmaxInsight's R&D Analytics Solution

Clinical Trial Optimization
Clinical Trial Optimization

  • Leverage data to gain insight into protocol and trial design, as well as the market and competitive dynamics that could affect trials.

  • Support the client in developing "What would be the best CT strategy to achieve drug approval" in a therapy area

Literature review analysis
Literature Review Analysis
  • Systematically collect, validate, and report on publication of research results.

  • Instantly compare health outcomes of two or more competing drugs of your choice based on systematically-reviewed clinical evidence.

Product Safety Analysis
Product Safety Analysis
  • Early drug safety trend and adverse event signal detection

  • Improved drug safety and operational effectiveness

  • Proactive unstructured data mining

Patent Analysis
Patent Analysis
  • Quickly find relevant patent from secondary search with global, accurate and precisely-indexed patent data to keep
    watch on generics entry / new MOA/ molecule

  • Patent documents are converted into a standard format, the bibliographic details are validated, and identified errors corrected.

Early Phase Research
Early Phase Research
  • Improve success rates in picking the right targets, gain greater insight into disease understanding, and better leverage the vast amount of data to accelerate your scientific discovery.

  • Manage your data and get testable hypotheses for disease mechanisms and subtypes, patient subpopulations, drug targets, biomarkers, treatment effect, and drug repositioning candidates through bioinformatics analysis and data & knowledge management.